Optimization and Characterization of a Liposomal Azithromycin Formulation for Alternative Macrophage Activation is a research paper published in Frontiers in Drug Delivery (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P20GM130456 R01NS116068 U01HL152392 R01HL152081
NINDS NIH HHS
Grant: R01 NS116068
NHLBI NIH HHS
Grant: U01 HL152392
NIGMS NIH HHS
Grant: P20 GM130456
NHLBI NIH HHS
Grant: R01 HL152081
National Institutes of Health
Grant: 5R01HL152081-03
Understanding the role of immune complexes between apolipoprotein A-I and IgG in atherosclerotic cardiovascular disease
National Institutes of Health
Grant: 5P20GM130456-03
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation
National Institutes of Health
Grant: 1U01HL152392-01
Kentucky Network for Innovation & Commercialization (“KYNETIC”)
National Institutes of Health
Grant: 5R01NS116068-03
Macrophage Depletion Therapy for Spinal Cord Injury
FWCI
0.08
Citation Percentile
0.3%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals